Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) EBITDA: 2019-2024

Historic EBITDA for IDEAYA Biosciences (IDYA) over the last 6 years, with Dec 2024 value amounting to -$274.2 million.

  • IDEAYA Biosciences' EBITDA rose 357.20% to $119.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$113.4 million, marking a year-over-year increase of 34.66%. This contributed to the annual value of -$274.2 million for FY2024, which is 150.37% down from last year.
  • IDEAYA Biosciences' EBITDA amounted to -$274.2 million in FY2024, which was down 150.37% from -$109.5 million recorded in FY2023.
  • In the past 5 years, IDEAYA Biosciences' EBITDA registered a high of -$34.6 million during FY2020, and its lowest value of -$274.2 million during FY2024.
  • In the last 3 years, IDEAYA Biosciences' EBITDA had a median value of -$109.5 million in 2023 and averaged -$148.2 million.
  • In the last 5 years, IDEAYA Biosciences' EBITDA climbed by 17.49% in 2020 and then crashed by 150.37% in 2024.
  • Yearly analysis of 5 years shows IDEAYA Biosciences' EBITDA stood at -$34.6 million in 2020, then crashed by 46.10% to -$50.5 million in 2021, then declined by 20.47% to -$60.8 million in 2022, then crashed by 80.10% to -$109.5 million in 2023, then crashed by 150.37% to -$274.2 million in 2024.